These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 27314875)

  • 1. High-Throughput Screening Uncovers Novel Botulinum Neurotoxin Inhibitor Chemotypes.
    Bompiani KM; Caglič D; Krutein MC; Benoni G; Hrones M; Lairson LL; Bian H; Smith GR; Dickerson TJ
    ACS Comb Sci; 2016 Aug; 18(8):461-74. PubMed ID: 27314875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacophore-guided lead optimization: the rational design of a non-zinc coordinating, sub-micromolar inhibitor of the botulinum neurotoxin serotype a metalloprotease.
    Burnett JC; Wang C; Nuss JE; Nguyen TL; Hermone AR; Schmidt JJ; Gussio R; Wipf P; Bavari S
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5811-3. PubMed ID: 19703771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent developments with metalloprotease inhibitor class of drug candidates for botulinum neurotoxins.
    Kumar G; Swaminathan S
    Curr Top Med Chem; 2015; 15(7):685-95. PubMed ID: 25751268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of library of betulin derivatives against the botulinum neurotoxin A protease.
    Šilhár P; Alakurtti S; Čapková K; Xiaochuan F; Shoemaker CB; Yli-Kauhaluoma J; Janda KD
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2229-31. PubMed ID: 21421315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel small molecule inhibitors of botulinum neurotoxin A metalloprotease activity.
    Burnett JC; Schmidt JJ; Stafford RG; Panchal RG; Nguyen TL; Hermone AR; Vennerstrom JL; McGrath CF; Lane DJ; Sausville EA; Zaharevitz DW; Gussio R; Bavari S
    Biochem Biophys Res Commun; 2003 Oct; 310(1):84-93. PubMed ID: 14511652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-throughput screening technologies for botulinum neurotoxins.
    Bompiani KM; Dickerson TJ
    Curr Top Med Chem; 2014; 14(18):2062-80. PubMed ID: 25335886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small tripeptide surrogates with low nanomolar affinity as potent inhibitors of the botulinum neurotoxin B metallo-proteolytic activity.
    Blommaert A; Turcaud S; Anne C; Roques BP
    Bioorg Med Chem; 2004 Jun; 12(11):3055-62. PubMed ID: 15142564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computer-aided identification, synthesis, and biological evaluation of novel inhibitors for botulinum neurotoxin serotype A.
    Teng YH; Berger WT; Nesbitt NM; Kumar K; Balius TE; Rizzo RC; Tonge PJ; Ojima I; Swaminathan S
    Bioorg Med Chem; 2015 Sep; 23(17):5489-95. PubMed ID: 26275678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A high-throughput-compatible FRET-based platform for identification and characterization of botulinum neurotoxin light chain modulators.
    Caglič D; Bompiani KM; Krutein MC; Čapek P; Dickerson TJ
    J Vis Exp; 2013 Dec; (82):50908. PubMed ID: 24430674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small molecule metalloprotease inhibitor with in vitro, ex vivo and in vivo efficacy against botulinum neurotoxin serotype A.
    Jacobson AR; Adler M; Silvaggi NR; Allen KN; Smith GM; Fredenburg RA; Stein RL; Park JB; Feng X; Shoemaker CB; Deshpande SS; Goodnough MC; Malizio CJ; Johnson EA; Pellett S; Tepp WH; Tzipori S
    Toxicon; 2017 Oct; 137():36-47. PubMed ID: 28698055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis/biological evaluation of hydroxamic acids and their prodrugs as inhibitors for Botulinum neurotoxin A light chain.
    Seki H; Pellett S; Silhár P; Stowe GN; Blanco B; Lardy MA; Johnson EA; Janda KD
    Bioorg Med Chem; 2014 Feb; 22(3):1208-17. PubMed ID: 24360826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of potent inhibitors of botulinum neurotoxin type B.
    Anne C; Turcaud S; Quancard J; Teffo F; Meudal H; Fournié-Zaluski MC; Roques BP
    J Med Chem; 2003 Oct; 46(22):4648-56. PubMed ID: 14561084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in botulinum neurotoxin inhibitor development.
    Kiris E; Burnett JC; Kane CD; Bavari S
    Curr Top Med Chem; 2014; 14(18):2044-61. PubMed ID: 25335887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hinge peptide combinatorial libraries for inhilbitors of botulinum neurotoxins and saxitoxin: deconvolution strategy.
    Moore GJ; Moore DM; Roy SS; Hayden LJ; Hamilton MG; Chan NW; Lee WE
    Mol Divers; 2006 Feb; 10(1):9-16. PubMed ID: 16404524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted 8-hydroxyquinoline fragment based small molecule drug discovery against neglected botulinum neurotoxin type F.
    Chauhan R; Chauhan V; Sonkar P; Vimal M; Dhaked RK
    Bioorg Chem; 2019 Nov; 92():103297. PubMed ID: 31557621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virtual medicinal chemistry: in silico pre-docking functional group transformation for discovery of novel inhibitors of botulinum toxin serotype A light chain.
    O'Malley S; Sareth S; Jiao GS; Kim S; Thai A; Cregar-Hernandez L; McKasson L; Margosiak SA; Johnson AT
    Bioorg Med Chem Lett; 2013 May; 23(9):2505-11. PubMed ID: 23545109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide inhibitors of botulinum neurotoxin serotype A: design, inhibition, cocrystal structures, structure-activity relationship and pharmacophore modeling.
    Kumar G; Kumaran D; Ahmed SA; Swaminathan S
    Acta Crystallogr D Biol Crystallogr; 2012 May; 68(Pt 5):511-20. PubMed ID: 22525749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of a novel metalloprotease inhibitor on botulinum neurotoxin B activity.
    Adler M; Nicholson JD; Cornille F; Hackley BE
    FEBS Lett; 1998 Jun; 429(3):234-8. PubMed ID: 9662424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The identification and biochemical characterization of drug-like compounds that inhibit botulinum neurotoxin serotype A endopeptidase activity.
    Cai S; Lindo P; Park JB; Vasa K; Singh BR
    Toxicon; 2010 Apr; 55(4):818-26. PubMed ID: 20003913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic substrate for application in both high and low throughput assays for botulinum neurotoxin B protease inhibitors.
    Salzameda NT; Barbieri JT; Janda KD
    Bioorg Med Chem Lett; 2009 Oct; 19(20):5848-50. PubMed ID: 19747823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.